<DOC>
	<DOCNO>NCT00353938</DOCNO>
	<brief_summary>This study look safety efficacy MDMA-assisted psychotherapy people posttraumatic stress disorder ( PTSD ) .</brief_summary>
	<brief_title>Study 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy People With Posttraumatic Stress Disorder</brief_title>
	<detailed_description>Posttraumatic stress disorder ( PTSD ) occur experience traumatic event event . PTSD public health problem cause great deal suffering . This study examine whether three six eight-hour long session methylenedioxymethamphetamine ( MDMA ) -assisted psychotherapy schedule three five week apart safely administered participant PTSD , whether combine fully therapeutic dose MDMA psychotherapy , compare low ( `` active placebo '' ) dose MDMA , reduce PTSD symptom , symptom measure three time study . People receive low dose MDMA opportunity take part second `` open label '' study continuation , wherein participant undergo three MDMA-assisted session , participant researcher know full dose MDMA administer . People receive full dose MDMA , person receive low-dose MDMA undergo open-label study continuation PTSD symptom measure six twelve month third session . People take part open label study continuation PTSD symptom check six 12 month third Phase II MDMA-assisted session . MDMA substance possess unique effect make well suit intensive psychotherapy . MDMA may belong new class drug , call entactogens , produce feeling closeness others , empathy , well , insightfulness . Currently , MDMA schedule ( illegal ) US Switzerland use outside research study like one . Anecdotal report therapy conduct MDMA make illegal suggest MDMA-assisted psychotherapy may benefit people PTSD , ongoing placebo-controlled study MDMA-assisted psychotherapy people crime war-related PTSD occur US . This study examine MDMA-assisted psychotherapy 12 individual age 18 year old diagnose PTSD , PTSD symptoms improve try least one treatment . Eight 12 participant assign receive full dose MDMA , four assign receive low `` active placebo '' dose MDMA three experimental session . People assign full low-dose MDMA `` chance , '' flip coin . The study last approximately four half month . In addition , people assign receive full-dose MDMA PTSD symptom measure six 12 month later . The study involve eleven ordinary psychotherapy visit , without MDMA , three low full-dose MDMA-assisted session . One psychotherapy session schedule 24 hour MDMA-assisted session . PTSD symptom measure start study , three week second three low full-dose MDMA session , three week third low full-dose MDMA session ( approximately six week second session ) , two month third experimental session , six 12 month either third experimental session , , enrol Phase II , six 12 month third open-label MDMA-assisted therapy session . Participants undergo EEG ( measure brain wave ) combination ERP ( evoke response potential ) technique MDMA-assisted therapy aim spot specific change brain function structure might relate problem early information processing , people PTSD know difficulty .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>N-Methyl-3,4-methylenedioxyamphetamine</mesh_term>
	<criteria>Diagnosed posttraumatic stress disorder ( PTSD ) . PTSD still remain one prior treatment , treatment include psychotherapy ( talk therapy ) drug therapy May meet criterion mood disorder Must least 18 year old Must able stop take psychiatric medication course study , start study followup two month experimental session 3 . Must agree follow rule instruction relate experimental session , include restriction food substance ( alcohol drug ) consumption . Must willing stay overnight researcher 's office experimental session nondrug session occur next morning . Must willing contact one researcher daily basis week experimental session . Female participant childbearing potential must negative pregnancy test must agree use effective form birth control . Participants must sufficient proficiency speak German language participate MDMAassisted psychotherapy . Participants must able read document German . Can history current primary psychotic disorder bipolar affective disorder1 . Dissociative identity disorder , eat disorder active purge borderline personality disorder . Evidence history significant hematological , endocrine , cerebrovascular , cardiovascular , coronary , pulmonary , renal , gastrointestinal , immunocompromising , neurological disease , include seizure disorder . ( People hypothyroidism adequate stable thyroid replacement exclude ) . Uncontrolled hypertension , peripheral vascular disease , hepatic disease ( without abnormal liver enzyme ) , history hyponatremia hyperthermia . Being pregnant lactating ( nursing ) , practice effective method birth control . Weight le 50 105 kg . Patients report prior use `` Ecstasy '' 5 time time within previous 6 month . People would present serious suicide risk likely require hospitalization course study . People need ongoing concomitant therapy psychotropic drug . Meeting DSMIV criterion substance abuse dependence substance save caffeine nicotine past 60 day . People give adequate consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>PTSD , MDMA , psychotherapy , Switzerland</keyword>
</DOC>